Recent Patents on Inflammation & Allergy Drug Discovery
Title:Advances in Developing Prophylactics and Therapeutics to Counter Inflammatory, Allergic and Infectious Diseases
Volume: 12 Issue: 1
Author(s): Ashok Munjal, Hafiz M.N. Iqbal and Kuldeep Dhama
Affiliation:
Export Options
About this article
Cite this article as:
Munjal Ashok , Iqbal M.N. Hafiz and Dhama Kuldeep , Advances in Developing Prophylactics and Therapeutics to Counter Inflammatory, Allergic and Infectious Diseases, Recent Patents on Inflammation & Allergy Drug Discovery 2018; 12 (1) . https://dx.doi.org/10.2174/1872213X1201180821095512
DOI https://dx.doi.org/10.2174/1872213X1201180821095512 |
Print ISSN 1872-213X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-2710 |
Related Articles
-
Challenging the Current Approaches to Multiple Myeloma-Related Bone Disease: From Bisphosphonates to Target Therapy
Current Cancer Drug Targets Reactive Intermediates and the Pathogenesis of Adverse Drug Reactions: The Toxicology Perspective
Current Drug Metabolism Editorial [Hot topic: Microbiota, Innate Immune and Anti-Inflammation (Guest Editor: Jun Sun)]
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Cyclin-Dependent Kinase Inhibitor p21CDKN1A as a Target of Anti-Cancer Drugs
Current Cancer Drug Targets Knowledge, Attitude and Practice of the use of Nanoparticles in the Treatment of Oral Cancer Patients
New Emirates Medical Journal Separate Toxin-Antidote Stabilization System in Two Plasmids for Recombinant Protein Production
Current Pharmaceutical Biotechnology Graphical Abstracts
Letters in Drug Design & Discovery Triterpene Derivatives as Inhibitors of Protein Involved in the Inflammatory Process: Molecules Interfering with Phospholipase A2, Cycloxygenase, and Lipoxygenase
Current Drug Targets Neuropeptides as Therapeutic Targets to Combat Stress-Associated Behavioral and Neuroendocrinological Effects
CNS & Neurological Disorders - Drug Targets Inflammasome as a New Therapeutic Target for Diabetic Complications
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Adverse Drug Reactions in Critical Care Settings: A Systematic Review
Current Drug Safety Dynamical Behaviors of the Transcriptional Network Including REST and miR-21 in Embryonic Stem Cells
Current Bioinformatics A Decade’s Review of miRNA: A Center of Transcriptional Regulation of Drugmetabolizing Enzymes and Transporters under Hypoxia
Current Drug Metabolism Immunossupressant and Organ Transplantation: Immunophilins Targeting Agent and Alternative Therapies
Current Medicinal Chemistry Drug Transport Across the Placenta
Current Pharmaceutical Biotechnology Recent Patents on Antimicrobial Peptides
Recent Patents on DNA & Gene Sequences Nanoemulsions for Skin Targeting: Present Status and Future Prospects
Drug Delivery Letters Therapeutic Enhancement of IL-2 Through Molecular Design
Current Pharmaceutical Design Phase 1 Clinical Experience Using Intravenous Administration of PV701, an Oncolytic Newcastle Disease Virus
Current Cancer Drug Targets Drug-Induced QTc Interval Prolongation: A Multicenter Study to Detect Drugs and Clinical Factors Involved in Every Day Practice
Current Drug Safety